GAL-201 prodrug (Galimedix Therapeutics)

N/A

Report date: 2026/05/20 20:02:01

Base Information

Drug NameGAL-201 prodrug (Galimedix Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionBeta amyloid A4 protein aggregation inhibitorsNeuroprotectants
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsGeographic AtrophyGlaucomaAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGalimedix Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesGalimedix Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsGeographic AtrophyGlaucomaAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A